Valuation : Acusphere, Inc.

Market Cap 3.46M 2.99M 2.83M 2.56M 4.81M 331M 4.84M 33.48M 12.91M 168M 13.01M 12.73M 533M P/E 2006
-1.06x
P/E 2007 -0.49x
Enterprise Value -11.29M -9.74M -9.22M -8.35M -15.66M -1.08B -15.77M -109M -42.07M -548M -42.39M -41.47M -1.74B EV / Sales 2006
9,811,030x
EV / Sales 2007 5,744,305x
Free-Float
100%
Yield 2006 *
-
Yield 2007 -
Change 5-day change 1-year change 3-year change Capi.($)
-1.13%-3.11%+13.82%+60.66% 46.21B
-1.13%-5.78%+33.26%+108.13% 38.78B
+0.12%-0.08%+7.12%+78.27% 11.68B
-0.53%-1.37%-13.25%+10.18% 11.55B
-0.38%-2.26%+18.18%+139.63% 9.14B
+0.32%-2.26%+23.08%+34.73% 7.3B
+0.17%-0.74%+13.44%+197.13% 7.15B
-1.00%-5.25%+34.34%-19.63% 7.1B
-3.13%-4.30%-44.88%+11.66% 4.97B
Average -0.74%-2.59%+9.46%+68.97% 15.99B
Weighted average by Cap. -0.86%-3.27%+16.06%+75.66%

Financials

2006 2007
Net sales 1.78 1.54 1.45 1.32 2.47 170.16 2.49 17.21 6.63 86.49 6.69 6.54 273.77 2.67 2.3 2.18 1.97 3.7 254.81 3.72 25.77 9.94 129.52 10.01 9.79 409.97
Net income -61.09M -52.71M -49.9M -45.19M -84.72M -5.84B -85.32M -590M -228M -2.97B -229M -224M -9.39B -53.73M -46.36M -43.88M -39.74M -74.52M -5.13B -75.04M -519M -200M -2.61B -202M -197M -8.26B
Net Debt -52.87M -45.62M -43.19M -39.11M -73.33M -5.05B -73.84M -511M -197M -2.57B -198M -194M -8.13B -14.76M -12.73M -12.05M -10.92M -20.47M -1.41B -20.61M -143M -54.98M -717M -55.4M -54.2M -2.27B
Logo Acusphere, Inc.
Acusphere, Inc. is a specialty pharmaceutical company. The Company is focused on the development of Imagify, which contains Perflubutane Polymer Microspheres for injectable suspension. The Company's product Imagify is a cardiovascular drug for the detection of coronary artery disease (CAD). Imagify injectable suspension consists of porous, synthetic polymer microspheres containing gas that are administered intravenously and act as tracers of blood flow or perfusion. The Company has submitted the Marketing Authorization Application (MAA) for its lead product candidate, Imagify lyophilisate for dispersion for injection with the European Medicines Agency (EMA) to support the regulatory review of Imagify in the European Union (EU).
Employees
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!